Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of Intensive Care Unit inpatients

International Journal of Antimicrobial Agents

Volumn 36, Issue 5, 2010, Pages 453-458

  Bado, Inés ^a   Cordeiro, Nicolás F ^a   Robino, Luciana ^a   García Fulgueiras, Virginia ^a   Seija, Verónica ^b   Bazet, Cristina ^b   Gutkind, Gabriel ^c   Ayala, Juan A ^d   Vignoli, Rafael ^a  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d CSIC   (Spain)

Author keywords

Integrons; Resistance; Transferable

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL ENZYME; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 9; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PER2 PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER; ENZYME ANALYSIS; GENE CASSETTE; GENE FREQUENCY; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; INTEGRON; INTENSIVE CARE UNIT; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PULSED FIELD GEL ELECTROPHORESIS; STOP CODON; URUGUAY;

EID: 77957653050     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.06.042     Document Type: Article

References (15)

1. Canton R., Coque T.M. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
2. Pallecchi L., Bartoloni A., Fiorelli C., Mantella A., Di Maggio T., Gamboa H., et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007, 51:2720-2725.
3. Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009, 22:664-689.
4. Quinteros M., Radice M., Gardella N., Rodriguez M.M., Costa N., Korbenfeld D., et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 2003, 47:2864-2867.
5. Marquez C., Labbate M., Raymondo C., Fernandez J., Gestal A.M., Holley M., et al. Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol 2008, 46:3417-3425.
6. Vignoli R., Cordeiro N., Seija V., Schelotto F., Radice M., Ayala J., et al. Genetic environment of CTX-M-2 in Klebsiella pneumoniae isolates from hospitalized patients in Uruguay. Rev Argent Microbiol 2006, 38:84-88. [in Spanish].
7. Marquez C., Labbate M., Ingold A.J., Chowdhury P.R., Ramirez M.S., Centron D., et al. Recovery of a functional class 2 integron from an Escherichia coli strain mediating a urinary tract infection. Antimicrob Agents Chemother 2008, 52:4153-4154.
8. Cordeiro N.F., Robino L., Medina J., Seija V., Bado I., Garcia V., et al. Ciprofloxacin-resistant enterobacteria harboring the aac(6′)-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay. Antimicrob Agents Chemother 2008, 52:806-807.
9. Vignoli R., Calvelo E., Cordeiro N.F., Lucero R., Ingold E., Quintana A., et al. Association of broad-spectrum antibiotic use with faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae in an intensive care unit. J Hosp Infect 2006, 63:306-315.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
11. Yang D., Guo Y., Zhang Z. Combined porin loss and extended spectrum β-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains. Curr Microbiol 2009, 58:366-370.
12. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006, 50:2872-2874.
13. Levings R.S., Lightfoot D., Partridge S.R., Hall R.M., Djordjevic S.P. The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol 2005, 187:4401-4409.
14. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
15. Song W., Suh B., Choi J.Y., Jeong S.H., Jeon E.H., Lee Y.K., et al. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment. Diagn Microbiol Infect Dis 2009, 65:447-449.